Table 1 Demographic data from the different populations.
RA | AS | Control | P | |
|---|---|---|---|---|
N = 105 | N = 83 | N = 56 | ||
Demographic characteristics | ||||
Age(mean(SD)) | 61.1 (9.5) | 56.5 (10.76)* | 65.2 (12.6) | 0.0001 |
Women(N(%)) | 82 (78.1) | 11 (13.3)* | 49 (87.5) | 0.0001 |
Smoking(N(%)) | 51 (48.6) | 37 (44.6) | 5 (8.9)** | 0.0001 |
Disease duration(median(IQR)) | 12.0 (7: 20.5) | 21 (9.5: 30) | / | 0.002 |
Biological inflammation(N(%)) | 70 (66.7) | 36 (43.4) | / | 0.004 |
Corticosteroid therapy(N(%)) | 86 (81.9) | 11 (13.25) | / | 0.0001 |
BMI(median(IQR)) | 26.1 (22.6: 32.4) | 25.4 (23.3: 30.9) | 27.4 (23.1: 37.6) | 0.384 |
Data on osteoporosis | ||||
Number of spine DXA(N(%)) | 104 (99) | 29 (34.9) | / | 0.0001 |
Osteoporosis on DXA (N (%)) | 28 (26.7) | 5 (6.02) | / | 0.22 |
Mean BMD on spine(mean(SD)) | 1.07 (0.2) | 1.16 (0.24) | / | 0.036 |
Clinical osteoporosis risk factor ≥2(N(%)) | 105 (100)‡ | 27 (32.5) | 2 (3.6) | 0.0001 |
Calcium and/or Vitamin D(N(%)) | 42 (40)‡ | 18 (21.68) | 4 (7.1) | 0.0001 |
Specific treatment(N(%)) | 37 (35.2)† | 13 (15.66) | 0 (0) | 0.002 |